---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058536"
form_type: "8-K"
ticker: "TRDA"
cik: "0001689375"
company_name: "Entrada Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:31:11.384074+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Entrada Therapeutics stockholders elect three Class I directors, ratify auditor

## Summary
- Elected Dipal Doshi (27,809,399 for, 429,248 withheld), Kush M. Parmar (24,883,797 for, 3,354,850 withheld), Mary Thistle (27,768,093 for, 470,554 withheld).
- Ratified Ernst & Young LLP as independent auditor for FY2025: 30,176,125 for, 74,925 against, 8,476 abstain.
- Broker non-votes on director election totaled 2,020,879 shares.
- Annual meeting held virtually on June 11, 2025; 30,259,526 shares represented (quorum).

## SEC filing metadata
- accession: 0001104659-25-058536
- form_type: 8-K
- ticker: TRDA
- cik: 0001689375
- company_name: Entrada Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/0001104659-25-058536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689375/000110465925058536/tm2517764d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058536
- JSON: https://secwatch.observer/filing/0001104659-25-058536.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058536.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.